The Lynne Cohen High Risk Screening and Prevention Project for
Ovarian and Breast Cancer at M.D. Anderson Cancer Center.
In this program, we offer each woman screening in the high-risk
ovarian screening clinic and the high-risk breast screening clinic.
These are clinics for women who are high risk for breast and ovarian
cancer. The criteria is 2 or more first or second degree relatives
with breast &/or ovarian cancer; or, 1 relative if patient
is of Ashkenazi Jewish descent. In the ovarian screening clinic,
we offer a visit with a gynecological oncologist, genetic counseling,
a transvaginal ultrasound, and a CA 125 blood test. In the breast
screening clinic, we offer breast cancer risk assessment including
genetic risk assessment by a genetic counselor, visit with a breast
medical oncologist, breast examination and screening (mammogram,
ultrasound and breast MRI if indicated).
The University of Texas M. D. Anderson Cancer Center
1. GOG-199: Study of Risk-Reducing Salpingo-Oophorectomy and CA-125
screening among women with an increased genetic risk of ovarian
cancer.
2. GYN01-142: Risk of Ovarian Cancer Algorhythm. Study of assessing
if CA-125 is helpful in early detection of ovarian cancer among
women at higher risk for this disease.
3. Lab03-0479: Prospective follow-up of women at increased risk
for breast cancer.
4. 2006-0185: Phase I Atorvastatin Breast Cancer Prevention Study
Dr. Karen Lu, Gynecologic Oncologist
Dr. Banu Arun, Breast Medical Oncologist
1. Personal or family history of breast or ovarian cancer
2. BRCA 1 or 2; family member(s) with breast &/or ovarian
cancer
3. Ashkenazi Jewish descent
713-563-4546
For more information about this program, please CLICK
HERE!
Back to Prevention Clinics or Back
To Clinical Trials
|
